CALIBRATE-PEDS: a phase 2/3, multicenter, single-arm study evaluating the pharmacokinetics, efficacy, and safety of encaleret in pediatric participants with autosomal dominant hypocalcemia type 1Stefano Mora, Rachel I. Gafni, Raja Padidela et al.|Endocrine Abstracts|2025Cited by 0
SUN-777 CALIBRATE-PEDS: A Phase 2/3, Multicenter, Single-Arm, Open-Label Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants with Autosomal Dominant Hypocalcemia Type1Peter J. Tebben, Rachel I. Gafni, Mary Scott Roberts et al.|Journal of the Endocrine Society|2025Cited by 0